Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide-Dexamethasone + Rituximab in Rituximab-Resistant NHL
NCT00783367Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jul 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in non-Hodgkin lymphoma (NHL), sponsored by Abramson Cancer Center. Started Jul 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00783367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00783367.